Page 18 - Journal of Structural Heart Disease Volume 2, Issue 1

Review Article
12
References
1. Go AS, Hylek EM, Phillips KA, et al. Prev- alence of diagnosed atrial brillation in adults: national implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370-2375. DOI: 10.1001/jama. 285.18.2370
2. Thom T, Haasne N, Rosamond W, et al. Heart disease and stroke statistics -2006 update: A report from the American Heart Asso- ciation Statistics Committee and Stroke Statistics Committee. Circulation. 2006; 113:e85-151. DOI: 10.1161/CIRCULATION- AHA.105.171600
3. Feinburg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial brillation. Analysis and implications. Arch Intern Med. 1995;155:469-473. DOI: 10.1001/ archinte.1995.00430050045005
4. Miyasaka Y, Barnes ME, Gersh BJ, et al. Sec- ular trends in incidence of atrial brillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006; 114:119-125. DOI: 10.1161/CIRCULATION- AHA.105.595140
5. Wang TJ, Larson MG, Levy D, et al. Tem- poral relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920- 2925. DOI: 10.1161/01.CIR.0000072767. 89944.6E
6. Ott A, Breteler MM, de Bruyne MC, et al. Atrial brillation and dementia in a popu- lation-based study. The Rotterdam Study. Stroke. 1997;28:316-321. DOI: 10.1161/01. STR.28.2.316
7. Kannel WB, Wolf PA, Benjamin EJ, et al. Prevalence, incidence, prognosis, and pre- disposing conditions for atrial brillation: population-based estimates. Am J Cardi- ol. 1998;82:2N-9N. DOI: 10.1016/S0002- 9149(98)00583-9
8. Wolf PA, Abbott RD, Kannel WB. Atrial bril- lation: A major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987;147:1561-1564. DOI: 10.1001/archinte.147.9.1561
9. Miller PS, Andersson FL, Kalra L. Are cost bene ts of anticoagulation for stroke pre- vention in atrial brillation underestimated? Stroke. 2005;36:360-366. DOI: 10.1161/01. STR.0000153002.56324.8c
10. Hart RG, Pearce LA, Aguilar MI. Meta-anal- ysis: antithrombotic therapy to prevent
stroke in patients who have nonvalvular atrial brillation. Ann Intern Med. 2007; 146:857-867. DOI: 10.7326/0003-4819-146- 12-200706190-00007
11. Waldo AL, Becker RC, Tapson VF, Colgan KJ. Hospitalized patients with atrial brilla- tion and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol. 2005;46:1729-1736. DOI: 10.1016/j.jacc.2005.06.077
12. Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S. Major hemorrhage and tolera- bility of warfarin in the rst year of therapy among elderly patients with atrial brilla- tion. Circulation. 2007;115:2689-2696. DOI: 10.1161/CIRCULATIONAHA.106.653048
13. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial brillation. N Engl J Med. 2009; 361:1139-1151. DOI: 10.1056/NEJMoa 0905561
14. Granger CB, Alexander JH, McMurray JJ, et al. Apixaban versus warfarin in pa- tients with atrial brillation. N Engl J Med. 2011;365:981-992. DOI: 10.1056/NEJMoa 1107039
15. Patel MR, Maha ey KW, Garg J, et al. Rivar- oxaban versus warfarin in nonvalvular atri- al brillation. N Engl J Med. 2011;365:883- 891. DOI: 10.1056/NEJMoa1009638
16. Blackshear JL, Odell JA. Appendage oblit- eration to reduce stroke in cardiac sur- gical patients with atrial brillation. Ann Thorac Surg. 1996;61(2):755-759. DOI: 10.1016/0003-4975(95)00887-X
17. Zabalgoita M, Halperin JL, Pearce LA, Blackshear JL, Asinger RW, Hart RG. Transe- sophageal echocardiographic correlates of clinical risk of thromboembolism in non- valvular atrial brillation: Stroke Preven- tion in Atrial Fibrillation III Investigators. J Am Coll Cardiol. 1998;31:1622-1626. DOI: 10.1016/S0735-1097(98)00146-6
18. Khurram IM1, Dewire J, Mager M, Maqbool F, Zimmerman SL, Zipun- nikov V, et al. Relationship between left atrial appendage morphology and stroke in patients with atrial brillation. Heart Rhythm. 2013;10(12):1843-1849. DOI: 10.1016/j.hrthm.2013.09.065
19. Di Biase L1, Santangeli P, Anselmi- no M, Mohanty P, Salvetti I, Gili S, et al. Does the left atrial appendage mor- phology correlate with the risk of stroke in patients with atrial brillation? Results from a multicenter study. J Am Coll Car- diol. 2012;60(6):531-538. DOI: 10.1016/j. jacc.2012.04.032
20.
21.
22.
23.
24.
25.
26.
27.
Conway D, Pearce LA, Chin PB, Hart RG, Lip G. Plasma von Willebrand factor and soluble p-selectin as indices of endothe- lial damage and platelet activation in 1321 patients with nonvalvular atrial bril- lation: Relationship to stroke risk factors. Circulation. 2002;106:1962-1967. DOI: 10.1161/01.CIR.0000033220.97592.9A
Lip G, Patel JV, Hughes E, Hart RG. High- sensitivity C-reactive protein and soluble CD40 ligand as indices of in ammation and platelet activation in 880 patients with nonvalvular atrial brillation: Relationship to stroke risk factors, stroke risk strati - cation schema, and prognosis. Stroke. 2007; 38:1227-1237. DOI: 10.1161/01.STR. 0000260090.90508.3e
January CT, Wann LS, Alpert JS, Calk- ins H, Cleveland JC Jr, Cigarroa JE, et al. 2014 AHA/ACC/HRS Guideline for the management of patients with atrial bril- lation: Executive Summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation. 2014; Apr 10.
Madden JL. Resection of the left auric- ular appendix: A prophylactic for recur- rent arterial emboli. J Am Med Assoc. 1949;140:769-772. DOI: 10.1001/jama. 1949.02900440011003
Kanderian AS1, Gillinov AM, Pet- tersson GB, Blackstone E, Klein AL. Success of surgical left atrial appendage closure: assessment by transesophageal echocardiography. J Am Coll Cardiol. 2008; 52(11):924-929. DOI: 10.1016/j.jacc.2008. 03.067
Wolf RK1, Schneeberger EW, Oster- day R, Miller D, Merrill W, Flege JB Jr, et al. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial brillation. J Thorac Car- diovasc Surg. 2005;130(3):797-802. DOI: 10.1016/j.jtcvs.2005.03.041
Johnson WD, Ganjoo AK, Stone CD, Srivyas RC, Howard M. The left atrial appendage: our most lethal human attachment! Sur- gical implications. Eur J Cardiothorac Surg. 2000;17:718-722. DOI: 10.1016/S1010- 7940(00)00419-X
Ohtsuka T, Nimomiya M, Nonaka T, Hisagi M, Ota T, Mizutani T. Thoracoscopic stand-alone left atrial appendectomy for thromboembolism prevention in non- valvular atrial brillation. J Am Coll Car- diol. 2013; 62:103-107. DOI: 10.1016/j. jacc.2013.01.017
Journal of Structural Heart Disease, February 2016
Volume 2, Issue 1:1-14